Clinical Trials in Boston

Showing 4641-4660 of 17,836 trials

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

NCT05563272

A prospective, open-label, phase 2 study to explore CAIX expression through 89Zirconium-labelled girentuximab deferoxamine (89Zr-girentuximab) PET/CT imaging in patients with solid tumors.

Cervical CancerColorectal CancerEsophageal Cancer+16 more

Telix Pharmaceuticals (Innovations) Pty Ltd11 participantsStarted Jun 2023

Los Angeles, California, United States • Miami, Florida, United States • Boston, Massachusetts, United States +7 more locations

TERMINATEDPhase 1< 1 mile

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

NCT02675452

The main objectives are to evaluate the safety and tolerability of AMG 176 monotherapy in participants with relapsed or refractory multiple myeloma and participants with relapsed or refractory acute myeloid leukemia.

Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Acute Myeloid Leukemia

Amgen141 participantsStarted Jun 2016

Duarte, California, United States • Sacramento, California, United States • Aurora, Colorado, United States +21 more locations

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Find Trials by Condition in Boston

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

RNS System NAUTILUS Study

GWICTIC: NAC Mechanistic Study in Gulf War Veterans

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

A Study in Participants With Non-cirrhotic NASH With Fibrosis

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)